Asia · Wires & real time · Focus Taiwan (CNA)

PharmaEssentia seeks to expand access to blood cancer drug in Europe

Published by Focus Taiwan (CNA) · Taiwan 12 h ago

Taiwan-based drugmaker PharmaEssentia Corp. is seeking to expand patient access to its blood cancer drug Ropeg in Europe, where the treatment has yet to receive regulatory…

Read the full article on Focus Taiwan (CNA) Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (focustaiwan.tw)

Also worth reading

Antara

Indonesia, WHO bolster herbal medicine control to tap economic benefit

VietnamPlus (VNA)

Meeting higher standards helps enhance competitiveness of Vietnam’s handicrafts

Press Trust of India

Bangladesh deploys additional paramilitary forces as garment workers’ protests continue

ANI (Asian News International)

9-year-old student dies after collapsing in classroom; police examine CCTV footage, investigation underway

Philippine News Agency

Over 7K Cordillera beneficiaries receive land titles from DAR

Xinhua Finance